← Back to Clinical Trials
Recruiting NCT07770438

NCT07770438 Evaluating the Effects of Reproductive Health Training on Provider Behavior - Aim 3

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07770438
Status Recruiting
Phase
Sponsor University of Minnesota
Condition Sexual and Reproductive Health
Study Type INTERVENTIONAL
Enrollment 650 participants
Start Date 2026-09-14
Primary Completion 2027-08-17

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Afrocentric Sexual and Reproductive Health Curriculum

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 650 participants in total. It began in 2026-09-14 with a primary completion date of 2027-08-17.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will evaluate the real-world effectiveness of a four-day Afrocentric sexual and reproductive health curriculum for health professional students in Tanzania. Medical, nursing, and midwifery students from the State University of Zanzibar, Kilimanjaro Christian University, and the University of Dodoma will receive the curriculum. The curriculum covers sexual health across the lifespan, sexual dysfunctions, key populations, sexual violence, clinical skills training, ethics, policy writing, community resources, and cultural considerations. Student outcomes will be assessed using surveys at baseline, immediately after the curriculum, and at 3-month and 12-month follow-up to examine changes in sexual health knowledge, attitudes, and sexual history and counseling skills.

Eligibility Criteria

Inclusion Criteria: * Current pre-final year student at the State University of Zanzibar, Kilimanjaro Christian University, or the University of Dodoma in midwifery, nursing, or medicine * Able to attend the full 4-day training * Fluent in English and Kiswahili * Willing to volunteer to complete all evaluation procedures Exclusion Criteria: * Unable to attend all days of the seminar at SUZA, KCMC, or UDOM * Unable to be on the SUZA, KCMC, or UDOM campus for the follow-up dates * Expresses reservations about attending, including religious objections * Expresses fear of violence due to attending, including fear from a spouse or relative * Prior exposure to the Training for Health Professionals curriculum or either of the previous pilots * Younger than 18 years of age * Non-English speaker * Unable to read * Employee of the researcher * Prisoner * Adult lacking capacity to consent or with diminished capacity to consent * Active member of the military or DoD personnel

Contact & Investigator

Central Contact

Koua A

✉ herxx159@umn.edu

📞 612-626-3500

Principal Investigator

B. R. Simon Rosser, PhD

PRINCIPAL INVESTIGATOR

University of Minnesota

Frequently Asked Questions

Who can join the NCT07770438 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Sexual and Reproductive Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07770438 currently recruiting?

Yes, NCT07770438 is actively recruiting participants. Contact the research team at herxx159@umn.edu for enrollment information.

Where is the NCT07770438 trial being conducted?

This trial is being conducted at Dodoma, Tanzania, Moshi, Tanzania, Zanzibar, Tanzania.

Who is sponsoring the NCT07770438 clinical trial?

NCT07770438 is sponsored by University of Minnesota. The principal investigator is B. R. Simon Rosser, PhD at University of Minnesota. The trial plans to enroll 650 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology